Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1832417rdf:typepubmed:Citationlld:pubmed
pubmed-article:1832417lifeskim:mentionsumls-concept:C0079488lld:lifeskim
pubmed-article:1832417lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:1832417lifeskim:mentionsumls-concept:C0106556lld:lifeskim
pubmed-article:1832417lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:1832417lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:1832417lifeskim:mentionsumls-concept:C0077407lld:lifeskim
pubmed-article:1832417pubmed:issue3lld:pubmed
pubmed-article:1832417pubmed:dateCreated1991-10-17lld:pubmed
pubmed-article:1832417pubmed:abstractTextThe combined activities of trospectomycin, a spectinomycin analogue, and colloidal bismuth subcitrate against Helicobacter pylori were investigated, the agar dilution method being employed. Forty-seven strains of H. pylori were examined. An additive effect was observed in 89%, and a synergistic interaction in 11% of the isolates. There was no antagonism observed. The MIC50 of trospectomycin against H. pylori was 2 mg/l; the MIC ranged from 0.5 to 4 mg/l.lld:pubmed
pubmed-article:1832417pubmed:languageenglld:pubmed
pubmed-article:1832417pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1832417pubmed:citationSubsetIMlld:pubmed
pubmed-article:1832417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1832417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1832417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1832417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1832417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1832417pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1832417pubmed:statusMEDLINElld:pubmed
pubmed-article:1832417pubmed:issn0300-8126lld:pubmed
pubmed-article:1832417pubmed:authorpubmed-author:HahnHHlld:pubmed
pubmed-article:1832417pubmed:authorpubmed-author:VogtKKlld:pubmed
pubmed-article:1832417pubmed:authorpubmed-author:RodloffA CAClld:pubmed
pubmed-article:1832417pubmed:issnTypePrintlld:pubmed
pubmed-article:1832417pubmed:volume19lld:pubmed
pubmed-article:1832417pubmed:ownerNLMlld:pubmed
pubmed-article:1832417pubmed:authorsCompleteYlld:pubmed
pubmed-article:1832417pubmed:pagination138-9lld:pubmed
pubmed-article:1832417pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:1832417pubmed:meshHeadingpubmed-meshheading:1832417-...lld:pubmed
pubmed-article:1832417pubmed:meshHeadingpubmed-meshheading:1832417-...lld:pubmed
pubmed-article:1832417pubmed:meshHeadingpubmed-meshheading:1832417-...lld:pubmed
pubmed-article:1832417pubmed:meshHeadingpubmed-meshheading:1832417-...lld:pubmed
pubmed-article:1832417pubmed:meshHeadingpubmed-meshheading:1832417-...lld:pubmed
pubmed-article:1832417pubmed:meshHeadingpubmed-meshheading:1832417-...lld:pubmed
pubmed-article:1832417pubmed:meshHeadingpubmed-meshheading:1832417-...lld:pubmed
pubmed-article:1832417pubmed:articleTitleCombined activity of trospectomycin and colloidal bismuth subcitrate against Helicobacter pylori in vitro.lld:pubmed
pubmed-article:1832417pubmed:affiliationInstitut für Medizinische Mikrobiologie, Freie Universität Berlin.lld:pubmed
pubmed-article:1832417pubmed:publicationTypeJournal Articlelld:pubmed